Genprex Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex’s oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
/ 
Frequently asked questions
To buy Genprex Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Genprex Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Genprex Inc. is GNPX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Genprex Inc. has its primary listing on NASDAQ. You can trade Genprex Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Genprex Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Genprex Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Genprex Inc..